Die direkten Kosten der Versorgung von Patienten mit Morbus Crohn aus der Perspektive der Gesetzlichen Krankenversicherung

Research output: Contribution to journalArticleResearchpeer review

Authors

  • A. Prenzler
  • T. Mittendorf
  • S. Conrad
  • J. M. Von Der Schulenburg
  • B. Bokemeyer

Research Organisations

External Research Organisations

  • Universität zu Lübeck
  • Gastroenterologische Gemeinschaftspraxis Minden
View graph of relations

Details

Translated title of the contributionCosts of Crohn's disease in Germany from the perspective of the Statutory Health Insurance
Original languageMultiple languages
Pages (from-to)659-666
Number of pages8
JournalZeitschrift fur Gastroenterologie
Volume47
Issue number7
Early online date15 Jul 2009
Publication statusPublished - Jul 2009

Abstract

Introduction: Data concerning treatment reality in patients with Crohn's disease (CD) are limited in Germany. The aim of this cross-sectional study was to collect resource use data due to CD and quantify these from the perspective of the Statutory Health Insurance in Germany. Methods: Between March 2006 and July 2007 the patients from 24 ambulatory gastroenterological specialist practices and 2 hospitals were enrolled in an internet-based online database. Based on the collected data, the outpatient and inpatient visits, all procedures as well as medication usage were determined and evaluated from the perspective of the Statutory Health Insurance taking also into consideration patient co-payments, company and pharmacy discounts. 2007 was selected as the price year. Results: Data from 511 CD patients were collected, with 37% being male. Patients were on average 41 years old. According to the calculations, an average CD patient in Germany causes costs of 3767.26 € from the perspective of the Statutory Health Insurance. 68.5% are medication costs, 20.5% result from inpatient care. The costs increase with the severity of the disease. Discussion: This is the first study to calculate costs due to CD (3767 €/year) from the perspective of the Statutory Health Insurance in Germany. To illustrate the costs from the societal perspective, indirect costs need to be included in the calculation in future studies.

ASJC Scopus subject areas

Cite this

Die direkten Kosten der Versorgung von Patienten mit Morbus Crohn aus der Perspektive der Gesetzlichen Krankenversicherung. / Prenzler, A.; Mittendorf, T.; Conrad, S. et al.
In: Zeitschrift fur Gastroenterologie, Vol. 47, No. 7, 07.2009, p. 659-666.

Research output: Contribution to journalArticleResearchpeer review

Prenzler A, Mittendorf T, Conrad S, Von Der Schulenburg JM, Bokemeyer B. Die direkten Kosten der Versorgung von Patienten mit Morbus Crohn aus der Perspektive der Gesetzlichen Krankenversicherung. Zeitschrift fur Gastroenterologie. 2009 Jul;47(7):659-666. Epub 2009 Jul 15. doi: 10.1055/s-0028-1109059
Download
@article{622972e1d27448288f22321bf46d771c,
title = "Die direkten Kosten der Versorgung von Patienten mit Morbus Crohn aus der Perspektive der Gesetzlichen Krankenversicherung",
abstract = "Introduction: Data concerning treatment reality in patients with Crohn's disease (CD) are limited in Germany. The aim of this cross-sectional study was to collect resource use data due to CD and quantify these from the perspective of the Statutory Health Insurance in Germany. Methods: Between March 2006 and July 2007 the patients from 24 ambulatory gastroenterological specialist practices and 2 hospitals were enrolled in an internet-based online database. Based on the collected data, the outpatient and inpatient visits, all procedures as well as medication usage were determined and evaluated from the perspective of the Statutory Health Insurance taking also into consideration patient co-payments, company and pharmacy discounts. 2007 was selected as the price year. Results: Data from 511 CD patients were collected, with 37% being male. Patients were on average 41 years old. According to the calculations, an average CD patient in Germany causes costs of 3767.26 € from the perspective of the Statutory Health Insurance. 68.5% are medication costs, 20.5% result from inpatient care. The costs increase with the severity of the disease. Discussion: This is the first study to calculate costs due to CD (3767 €/year) from the perspective of the Statutory Health Insurance in Germany. To illustrate the costs from the societal perspective, indirect costs need to be included in the calculation in future studies.",
keywords = "Cost analysis, Crohn's disease, Inflammatory bowel disease",
author = "A. Prenzler and T. Mittendorf and S. Conrad and {Von Der Schulenburg}, {J. M.} and B. Bokemeyer",
year = "2009",
month = jul,
doi = "10.1055/s-0028-1109059",
language = "Multiple languages",
volume = "47",
pages = "659--666",
journal = "Zeitschrift fur Gastroenterologie",
issn = "0044-2771",
publisher = "Karl Demeter Verlag GmbH",
number = "7",

}

Download

TY - JOUR

T1 - Die direkten Kosten der Versorgung von Patienten mit Morbus Crohn aus der Perspektive der Gesetzlichen Krankenversicherung

AU - Prenzler, A.

AU - Mittendorf, T.

AU - Conrad, S.

AU - Von Der Schulenburg, J. M.

AU - Bokemeyer, B.

PY - 2009/7

Y1 - 2009/7

N2 - Introduction: Data concerning treatment reality in patients with Crohn's disease (CD) are limited in Germany. The aim of this cross-sectional study was to collect resource use data due to CD and quantify these from the perspective of the Statutory Health Insurance in Germany. Methods: Between March 2006 and July 2007 the patients from 24 ambulatory gastroenterological specialist practices and 2 hospitals were enrolled in an internet-based online database. Based on the collected data, the outpatient and inpatient visits, all procedures as well as medication usage were determined and evaluated from the perspective of the Statutory Health Insurance taking also into consideration patient co-payments, company and pharmacy discounts. 2007 was selected as the price year. Results: Data from 511 CD patients were collected, with 37% being male. Patients were on average 41 years old. According to the calculations, an average CD patient in Germany causes costs of 3767.26 € from the perspective of the Statutory Health Insurance. 68.5% are medication costs, 20.5% result from inpatient care. The costs increase with the severity of the disease. Discussion: This is the first study to calculate costs due to CD (3767 €/year) from the perspective of the Statutory Health Insurance in Germany. To illustrate the costs from the societal perspective, indirect costs need to be included in the calculation in future studies.

AB - Introduction: Data concerning treatment reality in patients with Crohn's disease (CD) are limited in Germany. The aim of this cross-sectional study was to collect resource use data due to CD and quantify these from the perspective of the Statutory Health Insurance in Germany. Methods: Between March 2006 and July 2007 the patients from 24 ambulatory gastroenterological specialist practices and 2 hospitals were enrolled in an internet-based online database. Based on the collected data, the outpatient and inpatient visits, all procedures as well as medication usage were determined and evaluated from the perspective of the Statutory Health Insurance taking also into consideration patient co-payments, company and pharmacy discounts. 2007 was selected as the price year. Results: Data from 511 CD patients were collected, with 37% being male. Patients were on average 41 years old. According to the calculations, an average CD patient in Germany causes costs of 3767.26 € from the perspective of the Statutory Health Insurance. 68.5% are medication costs, 20.5% result from inpatient care. The costs increase with the severity of the disease. Discussion: This is the first study to calculate costs due to CD (3767 €/year) from the perspective of the Statutory Health Insurance in Germany. To illustrate the costs from the societal perspective, indirect costs need to be included in the calculation in future studies.

KW - Cost analysis

KW - Crohn's disease

KW - Inflammatory bowel disease

UR - http://www.scopus.com/inward/record.url?scp=69549088053&partnerID=8YFLogxK

U2 - 10.1055/s-0028-1109059

DO - 10.1055/s-0028-1109059

M3 - Article

C2 - 19606408

AN - SCOPUS:69549088053

VL - 47

SP - 659

EP - 666

JO - Zeitschrift fur Gastroenterologie

JF - Zeitschrift fur Gastroenterologie

SN - 0044-2771

IS - 7

ER -